Neuland Laboratories · NSE: NEULANDLAB · BSE: 524558
Q1 FY20 results · Apr–Jun 2019
Neuland Laboratories reported revenue from operations of ₹181.01 crore and net profit of ₹5.71 crore for Q1 FY20 (Apr–Jun 2019), on a consolidated basis.
| Item | Q1 FY20 | Q1 FY19 | YoY | Q4 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 181.01 | — | — | 0.00 | — |
| Other income | 0.52 | — | — | 0.00 | — |
| Total income | 181.53 | — | — | 0.00 | — |
| Profit before tax | 7.60 | — | — | 0.00 | — |
| Net profit for the period | 5.71 | — | — | 0.00 | — |
| EPS, basic (₹) | 4.45 | — | — | 0.00 | — |
| Net margin (%) | 3.2 | — | — |
| Item | Q1 FY20 | Q1 FY19 | YoY | Q4 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 181.01 | 153.96 | +17.6% | 172.66 | +4.8% |
| Other income | 0.52 | 1.11 | −53.5% | 1.33 | −61.2% |
| Total income | 181.53 | 155.07 | +17.1% | 174.00 | +4.3% |
| Profit before tax | 7.51 | 0.55 | 14x | 8.09 | −7.2% |
| Net profit for the period | 5.61 | 0.41 | 14x | 6.73 | −16.6% |
| EPS, basic (₹) | 4.38 | 0.35 | 13x | 5.25 | −16.6% |
| Net margin (%) | 3.1 | 0.3 | 3.9 |
Consolidated
- Filed with BSE
- 14 Aug 2019, 17:02 IST
- Board meeting
- 13 Aug 2019
- Period
- 01 Apr 2019 to 30 Jun 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 14 Aug 2019, 17:02 IST
- Board meeting
- 13 Aug 2019
- Period
- 01 Apr 2019 to 30 Jun 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE